Elutia Inc.

NasdaqCM:ELUT Stock Report

Market Cap: US$29.6m

Elutia Management

Management criteria checks 2/4

Elutia's CEO is Randy Mills, appointed in Jun 2022, has a tenure of 3.58 years. total yearly compensation is $4.54M, comprised of 13.2% salary and 86.8% bonuses, including company stock and options. directly owns 0.89% of the company’s shares, worth $262.67K. The average tenure of the management team and the board of directors is 3.6 years and 5.3 years respectively.

Key information

Randy Mills

Chief executive officer

US$4.5m

Total compensation

CEO salary percentage13.23%
CEO tenure3.6yrs
CEO ownership0.9%
Management average tenure3.6yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Lacklustre Performance Is Driving Elutia Inc.'s (NASDAQ:ELUT) 28% Price Drop

Dec 06
Lacklustre Performance Is Driving Elutia Inc.'s (NASDAQ:ELUT) 28% Price Drop

The Market Doesn't Like What It Sees From Elutia Inc.'s (NASDAQ:ELUT) Revenues Yet As Shares Tumble 30%

Oct 13
The Market Doesn't Like What It Sees From Elutia Inc.'s (NASDAQ:ELUT) Revenues Yet As Shares Tumble 30%

Elutia Inc.'s (NASDAQ:ELUT) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Aug 29
Elutia Inc.'s (NASDAQ:ELUT) Price Is Right But Growth Is Lacking After Shares Rocket 27%

US$6.50: That's What Analysts Think Elutia Inc. (NASDAQ:ELUT) Is Worth After Its Latest Results

Aug 19
US$6.50: That's What Analysts Think Elutia Inc. (NASDAQ:ELUT) Is Worth After Its Latest Results

Revenues Working Against Elutia Inc.'s (NASDAQ:ELUT) Share Price

Jun 18
Revenues Working Against Elutia Inc.'s (NASDAQ:ELUT) Share Price
User avatar

FDA Cleared EluPro Launch And Capacity Expansion Will Unlock Opportunity

EluPro's FDA clearance and market entry against Medtronic's TYRX could drive significant revenue growth in the antibiotic-eluting envelope space.

Elutia Inc. (NASDAQ:ELUT) Not Doing Enough For Some Investors As Its Shares Slump 27%

Jan 04
Elutia Inc. (NASDAQ:ELUT) Not Doing Enough For Some Investors As Its Shares Slump 27%

Elutia Inc. (NASDAQ:ELUT) Held Back By Insufficient Growth Even After Shares Climb 26%

Nov 20
Elutia Inc. (NASDAQ:ELUT) Held Back By Insufficient Growth Even After Shares Climb 26%

Elutia Inc.'s (NASDAQ:ELUT) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Jun 28
Elutia Inc.'s (NASDAQ:ELUT) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

News Flash: 2 Analysts Think Elutia Inc. (NASDAQ:ELUT) Earnings Are Under Threat

Mar 10
News Flash: 2 Analysts Think Elutia Inc. (NASDAQ:ELUT) Earnings Are Under Threat

Elutia Inc.'s (NASDAQ:ELUT) Share Price Is Matching Sentiment Around Its Revenues

Feb 21
Elutia Inc.'s (NASDAQ:ELUT) Share Price Is Matching Sentiment Around Its Revenues

Little Excitement Around Aziyo Biologics, Inc.'s (NASDAQ:AZYO) Revenues As Shares Take 63% Pounding

Apr 17
Little Excitement Around Aziyo Biologics, Inc.'s (NASDAQ:AZYO) Revenues As Shares Take 63% Pounding

CEO Compensation Analysis

How has Randy Mills's remuneration changed compared to Elutia's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-US$25m

Jun 30 2025n/an/a

-US$22m

Mar 31 2025n/an/a

-US$40m

Dec 31 2024US$5mUS$600k

-US$54m

Sep 30 2024n/an/a

-US$53m

Jun 30 2024n/an/a

-US$65m

Mar 31 2024n/an/a

-US$49m

Dec 31 2023US$2mUS$600k

-US$41m

Sep 30 2023n/an/a

-US$32m

Jun 30 2023n/an/a

-US$35m

Mar 31 2023n/an/a

-US$38m

Dec 31 2022US$2mUS$321k

-US$36m

Sep 30 2022n/an/a

-US$39m

Jun 30 2022n/an/a

-US$37m

Mar 31 2022n/an/a

-US$28m

Dec 31 2021US$146kn/a

-US$25m

Sep 30 2021n/an/a

-US$21m

Jun 30 2021n/an/a

-US$23m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$142kn/a

-US$25m

Compensation vs Market: Randy's total compensation ($USD4.54M) is above average for companies of similar size in the US market ($USD591.09K).

Compensation vs Earnings: Randy's compensation has increased whilst the company is unprofitable.

CEO

Randy Mills (53 yo)

3.6yrs
Tenure
US$4,536,157
Compensation

Dr. C. Randal Mills, Ph D., also known as Randy, has been Director of Elutia Inc. (formerly known as Aziyo Biologics, Inc.) since November 2015. Dr. Mills served as a Member of Advisory Board at eXpanded e...

Leadership Team

NamePositionTenureCompensationOwnership
C. Mills
Co-Founder3.6yrsUS$4.54m0.89%
$ 262.7k
Matthew Ferguson
Chief Financial Officer5.3yrsUS$1.81m1.05%
$ 309.7k
Michelle Williams
Chief Scientific Officer3.4yrsUS$1.60m0.24%
$ 70.6k
Sonali Fonseca
VP & Head of Emerging Businesses4yrsno datano data
Dwayne Montgomery
Head of Cardiovascularless than a yearno datano data
Jeffry Hamet
Senior VP of Financeno datano datano data
3.6yrs
Average Tenure
55yo
Average Age

Experienced Management: ELUT's management team is considered experienced (3.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
C. Mills
Co-Founder10.2yrsUS$4.54m0.89%
$ 262.7k
Kevin Rakin
Independent Chairman & Lead Independent Director10.2yrsUS$321.50k1.05%
$ 310.7k
Brigid Makes
Independent Director5.3yrsUS$161.00k0.063%
$ 18.7k
Guido Neels
Directorless than a yearno data0.16%
$ 47.6k
David Colpman
Independent Director3.3yrsUS$138.50k0.073%
$ 21.5k
5.3yrs
Average Tenure
64yo
Average Age

Experienced Board: ELUT's board of directors are considered experienced (5.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/02 09:54
End of Day Share Price 2025/12/31 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Elutia Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brandon FolkesCantor Fitzgerald & Co.
Ross OsbornCantor Fitzgerald & Co.
Frank TakkinenLake Street Capital Markets, LLC